DayTraders Review

Our verdict on DayTraders

DayTraders is a one-time-fee proposition whose simplicity is attractive only if the payout record catches up with the launch story. Separate its education offer from evidence that funded traders actually withdraw. DayTraders is the heavyweight allocation play: the firm with the largest total funded capital we track — $4.5 million across 15 accounts — and the largest single account size in our leading firms at $300K, paired with a 100% profit split and automated payout approval. Founded in 2023 and built on its proprietary ONYX platform, DayTraders tripled its account ceiling in April 2026 (from 5 funded accounts to 15) in a direct challenge to Apex's scaling monopoly. The main trade-offs: trailing drawdown only across the entire lineup, a Rithmic-only data feed, and the smallest review base in our leading firms (459 Trustpilot reviews). DayTraders ranks #9 of 66 at 77/100.

DayTraders is best suited for well-capitalized size traders — anyone whose strategy needs a $300K single account rather than stitching together $150K units, and scalers who want Apex-class parallel allocation (15 × $300K) at 100% split without Apex's bot ban ambiguity on discretionary execution. The automated payout approval also appeals to traders burned by discretionary payout reviews elsewhere. It's less suited for trailing-drawdown refusers — there is no EOD or static option anywhere in the lineup, full stop — and for anyone who needs Tradovate or TradingView, neither of which is supported.

Three things separate DayTraders from the pack. First, the allocation ceiling: $4.5M total and $300K single accounts are both category records among our monitored firms; the April 2026 change tripling funded accounts (5→15) and raising S2F accounts (3→5) was one of the most trader-favorable rule changes we logged this year. Second, the payout stack: 100% profit split — matched only by Apex — with automated approval removing the human-review bottleneck, and a verified track record our feed confirms: $2.7M paid across 1,187 logged payouts, with a cluster of verified payouts ($850–3,000 each) landing within the last several hours as of this review. Third, the Straight-to-Funded (S2F) route: skip the evaluation entirely and buy funded status, now up to 5 S2F accounts — the fastest capital access in the firm's lineup for traders who price their time above the fee difference.

The watch-outs: trailing drawdown is the whole risk model here — 5% trailing on every account size ($1,250 on 25K, $2,500 on 50K) — and trailing DD punishes exactly the give-back patterns that big-size trading produces. Know your MAE statistics before buying size. Second, the pricing structure is bimodal: list prices are the highest in the leading firms ($249–879), but promos regularly compress them by 80–90% ($22 for a 25K, $34–79 across the lineup); activation is now $99 across every account size. Never buy at list. Third, the trust base is thin relative to peers: 459 reviews and a 2023 founding produce a Health Score 66/100 — the verified payout feed partially compensates, but this is a younger, smaller book than the leading firms.

On platforms: Rithmic feed only, with ATAS, Quantower and R Trader Pro. That's a professional order-flow stack — arguably the point, given the firm's positioning — but it excludes the Tradovate/TradingView mainstream entirely. If your workflow lives in TradingView, this firm is not for you.

Reading the score: DayTraders' 76 pairs record highs with real discounts. The split component maxes at 100% (shared only with Apex) and max accounts scores 75% — second-best in the index. Editorial-and-data quality is a solid 86% and minimum trading days 100%. The drags are explicit: price at the 50K benchmark scores just 52%, the leading firms's weakest, because the promo-dependent pricing plus DayTraders' $99 activation fee still makes all-in economics worth checking; the platform component sits at 50% (Rithmic-only feed); and the Health contribution of 66 carries the thin review base (72% volume component) and 2023 founding. The algorithm's read: best-in-class payout terms, priced and verified like a challenger — buy on promo, or not at all.

Our verdict: DayTraders is the most credible challenger to Apex's scaling crown, and on single-account size it has already won. The current score reflects a genuinely differentiated offer (100% split, automated payouts, record allocation) discounted for the trailing-only risk model and a still-maturing trust base. For experienced traders who manage trailing drawdown well and want maximum size, this is a serious option; for everyone else, the leading firms offers friendlier risk geometry.

Best fit

DayTraders is best suited for well-capitalized size traders — anyone whose strategy needs a $300K single account rather than stitching together $150K units, and scalers who want Apex-class parallel allocation (15 × $300K) at 100% split without Apex's bot ban ambiguity on discretionary execution. The automated payout approval also appeals to traders burned by discretionary payout reviews elsewhere.

Not ideal for

It's less suited for trailing-drawdown refusers — there is no EOD or static option anywhere in the lineup, full stop — and for anyone who needs Tradovate or TradingView, neither of which is supported.

PropScore

DayTraders: #9, PropScore 77/100, Health Score 66/100. Updated from live tracked data: August 31, 2026.